DESIGN OF MEDIUM CHAIN FATTY ACID MONOGLYCERIDES TO CONTROL PATHOLOGIES OF THE PORCINE ENTERIC COMPLEX (1/2) (Q3170870): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): 3F is an SME specialising in the production of feed additives, and in particular wants to develop medium-chain fatty acid monoglycerides to reduce the incidence of porcine enteric complex. VC is a large company of a leading European pig production business group, with a slaughter volume of approximately 4 million pigs, and which wants to lay the foundation for a live pig production system without or with minimised use of antibiotics._x000D_ The...) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
DESIGN OF MEDIUM CHAIN FATTY ACID MONOGLYCERIDES TO CONTROL PATHOLOGIES OF THE PORCINE ENTERIC COMPLEX (1/2) | |||
Revision as of 18:04, 12 October 2021
Project Q3170870 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DESIGN OF MEDIUM CHAIN FATTY ACID MONOGLYCERIDES TO CONTROL PATHOLOGIES OF THE PORCINE ENTERIC COMPLEX (1/2) |
Project Q3170870 in Spain |
Statements
262,673.0 Euro
0 references
525,346.0 Euro
0 references
50.0 percent
0 references
1 August 2017
0 references
31 December 2019
0 references
3F FEED AND FOOD SL
0 references
40°39'23.33"N, 4°42'0.79"W
0 references
05019
0 references
3F es una PYME especializada en la producción de aditivos para alimentación animal, y en particular desea desarrollar monoglicéridos de ácidos grasos de cadena media para disminuir la incidencia del complejo entérico porcino. VC es una gran empresa de un grupo empresarial líder en producción porcina a escala europea, con un volumen de sacrificio de 4 millones de cerdos aproximadamente, y que desea sentar las bases de un sistema de producción de cerdo vivo sin antibióticos o con un uso minimizado de los mismos._x000D_ El objetivo del proyecto es el diseño de nuevos sistemas de alimentación para el cerdo blanco basados en la adición de monoglicéridos de ácidos grasos de cadena media y en modificaciones sustanciales del perfil nutricional de la dieta para controlar de forma preventiva patologías del complejo entérico porcino. El objetivo empresarial de 3F es aumentar su cartera mediante el desarrollo de una gama nueva de productos para el tratamiento preventivo del complejo entérico porcino, mientras que VC desea disminuir la mortalidad y aumentar la productividad del cerdo blanco producido en sistemas sin antibióticos, y disminuir los costes de medicación en los sistemas tradicionales de producción de cerdo blanco. _x000D_ El proyecto tiene una duración de 29 meses y se divide en 10 tareas experimentales distribuidas en 3 actividades de Desarrollo Tecnológico: i) Diseño de nuevos sistemas de síntesis y formulaciones basadas en monoglicéridos de ácidos grasos de cadena media; ii) Mejora de la salud intestinal durante la transición y la entrada a cebadero mediante el diseño de nuevos perfiles nutricionales de la dieta; y iii) Estudio de la influencia de la interacción entre el perfil nutricional y los nuevos monoglicéridos sobre el complejo digestivo porcino. Para la realización de cada una de las actividades, las empresas contarán con la colaboración de la Universidad Católica de Ávila, del laboratorio Grup de Sanejament Porcí y empresas especializadas (Innovabiotics e Imasde). (Spanish)
0 references
3F is an SME specialising in the production of feed additives, and in particular wants to develop medium-chain fatty acid monoglycerides to reduce the incidence of porcine enteric complex. VC is a large company of a leading European pig production business group, with a slaughter volume of approximately 4 million pigs, and which wants to lay the foundation for a live pig production system without or with minimised use of antibiotics._x000D_ The aim of the project is to design new feeding systems for white pigs based on the addition of medium chain fatty acid monoglycerides and substantial modifications to the nutritional profile of the diet to prevent the pathologies of the pig enteric complex. The business objective of 3F is to increase its portfolio by developing a new range of products for the preventive treatment of the porcine enteric complex, while VC wants to reduce mortality and increase the productivity of white pig produced in systems without antibiotics, and reduce medication costs in traditional white pig production systems. _x000D_ the project lasts 29 months and is divided into 10 experimental tasks distributed into 3 technological development activities: design of new synthesis systems and formulations based on medium chain fatty acid monoglycerides; improvement of intestinal health during transition and entry into feedstock through the design of new nutritional profiles of the diet; and (iii) Study of the influence of the interaction between the nutritional profile and the new monoglycerides on the porcine digestive complex. For the realisation of each of the activities, the companies will have the collaboration of the Catholic University of Avila, the laboratory Grup de Sanejament Porcí and specialised companies (Innovabiotics and Imasde). (English)
12 October 2021
0 references
Ávila
0 references
Identifiers
IDI-20180097
0 references